Abstract

The field of immunopharmacology is revolutionizing cancer therapy by enhancing antitumor immunity through innovative pharmacological interventions. This article reviews the role of immunopharmacology in cancer treatment, focusing on strategies to boost the immune system’s ability to target and eliminate tumor cells. We explore key pharmacological agents, including checkpoint inhibitors, immune modulators, and targeted therapies, and their mechanisms of action. Additionally, the article examines the challenges and future directions in integrating these therapies into clinical practice, highlighting the potential for improved patient outcomes and personalized treatment approaches. By bridging pharmacological advances with immunological insights, this review underscores the transformative potential of immunopharmacology in cancer therapy.